Table 4

Health outcomes in treatment-naïve HCV patients and matched controls
HCV never treated Matched controls p-value
(n = 139) (n = 139)
M SD M SD
Work productivity & activity impairment
 Absenteeism 6.67% 18.26% 2.84% 13.36% .157
 Presenteeism 24.84% 30.07% 12.86% 21.28% .006
 Overall work impairment 28.65% 32.94% 14.75% 24.57% .004
 Activity impairment 31.73% 30.57% 29.28% 31.48% .374
Healthcare resource utilization
 Physician visits 19.54 24.62 12.06 16.80 .001
 ER visits 0.46 1.90 0.35 1.15 .986
 Hospitalizations 0.36 1.16 0.19 0.99 .120
Quality of life (SF-12v2)
 MCS 44.72 10.43 45.93 11.64 .361
 PCS 43.49 10.26 45.99 10.72 .048
 Health utility 0.68 0.13 0.71 0.15 .080

Comparisons of work productivity impairment are based on 65 treatment-naïve HCV patients and 65 matched controls. All other comparisons include the entire samples.

Vietri et al.

Vietri et al. BMC Gastroenterology 2013 13:16   doi:10.1186/1471-230X-13-16

Open Data